Bringing a drug to market is a long and costly process from discovery to delivery. Translations are required at various stages of the product lifecycle including clinical research, regulatory submissions, labeling, and marketing & commercialization. At Morningside, we know that translation errors can lead to costly delays in time-to-market, so our rigorous quality controls are certified to the latest ISO 9001, 13485, and 17100 standards. For over 20 years, Morningside has supported leading pharma and biotech companies with high-quality pharmaceutical translation services that comply with all local regulatory requirements, minimize risk, and help our clients deliver reliable outcomes to patients worldwide.
Deliver better outcomes with trusted translation and validation solutions.
Ensure regulatory approval with reliably accurate translations for required documentation.
Reduce risk and ensure comprehension with Specialized medical interpretation expertise.
As clinical trials have become more international in scope, precise translations and rigorous quality processes have become even more essential. Morningside has proven expertise in a wide range of medical and therapeutic fields, from translation of clinical trial agreements and protocols, to study budget planning and linguistic validation. Our translators deliver clinical document translations that are culturally adapted for the intended target audience and comply with all local regulatory requirements.
Morningside employs ISO 13485, 9001 and 17001 compliant processes and controls, as well as a 3-tier linguistic review process to ensure accurate translations. As an added step to mitigate risk, our proprietary algorithm, Quality Reliability Indicator (QRI), monitors projects, identifies areas of concern and helps prevent errors before they happen for a reliable and repeatable outcome.
Morningside gets ideas right, providing reliable pharmaceutical translation services for every stage of the product lifecycle. In the discovery stage, drug and biotech companies rely on us to help patent and protect their ideas abroad. Sponsors and CROs partner with Morningside during the clinical stage to plan their budgets, translate their documentation and validate their COAs. In preparation for regulatory approval, we provide translation services for a range of regulatory documentation from labeling, packaging, and IFUs, to EC/IRB Correspondence, NDAs and INDs. Finally, when it is time to enter foreign markets, we localize and culturally adapt marketing materials, websites, eIFUs and eLearning modules. To round out the product lifecycle, we provide translations for post-market adverse event reporting.
Morningside utilizes industry-leading technology to help lower costs, improve quality and enhance your customer experience. Translation memory (TM) tools, for example, allow us to leverage previous translations to speed up delivery, ensure consistency and lower costs. We also make it easy for you to manage your projects through our secure online platforms. You can get quotes, submit new projects, and download completed translations on our Life Science Platform and review and edit completed translations via our In-Country Review Platform.
Contact our team to discuss how we can help.